Medical prescriptions-off label purposes.

HB 119 authorizes Wyoming prescribers (physicians, physician assistants, dentists, and advanced practice nurses) and pharmacists to prescribe and dispense FDA-approved medications for off-label uses - treatments not specified in the drug's FDA labeling - without facing disciplinary action from licensing boards or employers. The bill explicitly excludes Schedule I/II controlled substances under federal law. It provides legal immunity from civil lawsuits or professional discipline for healthcare providers acting under these provisions, defining "off-label indication" as using approved drugs for unapproved medical purposes. The law takes effect July 1, 2023.